Article

One effect and two causes: Growth acceleration and breast cancer risk after hormone replacement therapy

2024-02-17

Abstract excerpt

<h4>Background</h4> An increased risk for breast cancer (BC) following hormone replacement therapy (HT) with estrogen and progesterone in women has been reported in several studies. However, HTs are associated with two distinct effects, a BC risk (RF) and an acceleration of BC growth (GAF). The interaction of both effects is analyzed. <h4>Methods</h4> Using data from the U.S. population on BC incidence and life ex...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2bb9f0fb-b6e4-5b21-be7f-e7f19e5dc00b
DOI: 10.1101/2024.02.16.24302914

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

One effect and two causes: Growth acceleration and breast cancer risk after hormone replacement therapyDOI 10.1101/2024.02.16.24302914Read

Hormone replacement therapy and elevated breast cancer risk: An artifact of growth acceleration?Semantic proximity Read

Trends in the Incidence and Survival of Women with Hormone Receptor-Positive Breast Cancer from 1990–2019: A Large Population-Based AnalysisSemantic proximity Read

Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy.Semantic proximity Read

Breast cancer prevention: present and future.Semantic proximity Read

Incidence and temporal patterns of true recurrences and second primaries in women with breast cancer: a 10-year competing risk-adjusted analysisSemantic proximity Read

Ageing phenotypes and behavioural determinants of health on age acceleration: the Cancer Survivors' Trajectories of Ageing Research (C*STAR) study protocol.Semantic proximity Read

Breast cancer: Emerging principles of metastasis, adjuvant and neoadjuvant treatment from cancer registry dataSemantic proximity Read

What can be learnt from models of incidence rates?Semantic proximity Read

Differential Second Primary Malignancy Occurrence After Breast Cancer According to HER2 Status: a SEER Population-Based AnalysisSemantic proximity Read

Risk of myocardial infarction and stroke after female breast cancer: analysis on a cohort of 1.3 million womenSemantic proximity Read

Longitudinal trajectory of menopausal symptoms in premenopausal women throughout adjuvant chemotherapy: a two-stage analytical approachSemantic proximity Read

The menopause, hormone replacement therapy and breast cancer.Semantic proximity Read